CB
CRNX

Commerce Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History

Commerce Bank’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Sell
8,002
-24
-0.3% -$892 ﹤0.01% 1158
2026
Q1 		$292K Buy
8,026
+7
+0.1% +$313 ﹤0.01% 1144
2025
Q4 		$373K Buy
8,019
+444
+6% +$19.8K ﹤0.01% 987
2025
Q3 		$315K Sell
7,575
-410
-5% -$13.1K ﹤0.01% 1041
2025
Q2 		$230K Buy
7,985
+1,665
+26% +$51.4K ﹤0.01% 1118
2025
Q1 		$212K Buy
6,320
+2,195
+53% +$82K ﹤0.01% 1127
2024
Q4 		$211K Sell
4,125
-30
-0.7% -$1.68K ﹤0.01% 1130
2024
Q3 		$212K Buy
+4,155
New +$214K ﹤0.01% 1160

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Commerce Bank's CRNX Position: Q2 2026 in Review

Commerce Bank reduced its Crinetics Pharmaceuticals (CRNX) stake by 0.3% in Q2 2026, selling an estimated $892 and leaving 8,002 shares worth $299K. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

Commerce Bank first reported a position in CRNX in Q3 2024 and has held it in 8 quarters since. The position peaked at $373K in Q4 2025. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Commerce Bank held 8,002 shares of Crinetics Pharmaceuticals worth $299K as of Q2 2026.
  • Commerce Bank sold 24 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $892.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #1158 holding.
  • Commerce Bank first reported a position in Crinetics Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Commerce Bank's Crinetics Pharmaceuticals position peaked at $373K in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.